Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) and Forecast 2017-2021

Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) and Forecast 2017-2021

Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. Higher prevalence of prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, unwanted pregnancies and rapidly aging global population are the driving the global implantable drug delivery devices market.

The global implantable drug delivery devices market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on device type (bio-absorbable stents, brachytherapy seeds, contraceptive devices, coronary drug eluting stents, drug infusion pumps, and intraocular devices), their underlying technologies (biodegradable and non-biodegradable), its applications (contraception, cardiovascular, oncology, ophthalmology, diabetes, chronic pain, etc.), and also forecasts growth trends (CAGR% – 2017 to 2021).

The global implantable drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global implantable drug delivery devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global implantable drug delivery devices market and included in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Implantable Drug Delivery Devices Market

1. Device Type
1.1. Bio-Absorbable Stents
1.2. Brachytherapy Seeds
1.3. Contraceptive Devices
1.4. Coronary Drug Eluting Stents
1.5. Drug Infusion Pumps
1.6. Intraocular Devices

2. Technology
2.1. Biodegradable Drug Delivery Technology
2.2. Non-Biodegradable Drug Delivery Technology

3. Application
3.1. Birth Control (Contraception)
3.2. Cardiovascular
3.3. Oncology
3.4. Ophthalmology
3.5. Others (Diabetes, Chronic Pain)

4. Company Profiles
4.1. Abbott Laboratories
4.2. Allergan, Inc.
4.3. Bausch & Lomb Inc.
4.4. Bayer Healthcare
4.5. Boston Scientific Corporation
4.6. Medtronic Inc.
4.7. Merck
4.8. Nucletron
4.9. Psivida Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish